Tuesday 4 March 2008
Subscribe to:
Post Comments (Atom)
skip to main |
skip to sidebar
NEWS AND VIEWS FROM THE PHARMACEUTICAL FINE CHEMICAL AND CUSTOM MANUFACTURING SECTOR
Fine
The FINE blog keeps you up-to-date on the pharmaceutical fine chemical and custom manufacturing sector. The weekly FINE Newsletter gives senior pharmaceutical fine chemical and custom manufacturing leaders a weekly summary of the key news stories and trends for the sector. The FINE Newsletter and blog focus on coverage of companies in the pharmaceutical fine chemical custom manufacturing sector, without forgetting key news from their customers in the pharma industry.
Subscribe
To receive the newsletter, each week, please subscribe.
Advertising
|
|
|
|
||
| Read this FREE online! Full Book | PDF Summary | Podcast | ||
Blog Archive
-
▼
2008
(457)
-
▼
March
(43)
- FDA may fail
- Acquisitions for Lonza?
- Rhodia to dismantle Organics business
- WC Heraeus will manufacture picoplatin for Poniard...
- FDA plans to reduce drug development costs
- Cambrex customer recalls product
- Avecia sells vaccines
- Archimica will manufacture the API for NicOx's lea...
- China's State Food and Drug Administration now gov...
- Eleven now interested in Evonik
- Biotech offsets fine chemicals decline for Wacker
- New projects boost Siegfried profits
- Goodwin Biotechnology to manufacture antibody for ...
- GMP not required for excipients
- More money proposed for FDA
- Good 2007 for Evonik, still looking for sale
- FDA increases China staff
- CMC ICOS will develop a production cell line for R...
- Hikal invests in manufacturing
- RFCL on European shopping spree
- Cobra Biomanufacturing has received R&D tax credit...
- Nicholas Piramal seeks Euro/US acquisition
- Asian competition forces Rhodia to close last para...
- Analyst: Fewer NME approvals expected in 2008
- Lanxess sets criteria for acquisitions
- Woodcock reappointed to head CDER
- DSM, Crucell see 15gl-1 yield with PER.C6
- EMEA expects record year
- Evonik puts IPO on hold
- Lonza manufactures clinical trial material for iCo...
- Explosion at Synthetech facility
- SOCMA opposes IST legislation
- Link Technologies opens new kilo-scale facilities
- Evonik acquires in China
- 10 bidders lined up for Evonik
- Hovione invests in China
- Merck invests in research centre
- Eden in manufacturing deal with Stealthyx
- Hikal to supply active ingredients for Bayer CropS...
- Pfizer plans more outsourcing to keep costs down
- GAO to investigate FDA approval process
- DSM sells Special Products unit to Arsenal Capital...
- Cambrex contests fire and explosion fines
-
▼
March
(43)
Technorati
Copyright ©2007, 2008 FINE. All rights reserved.
No comments:
Post a Comment